Business
Persistent Launches AI-Powered Generative Molecules and Virtual Screening Solution Powered by NVIDIA
Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today announced it is working with NVIDIA to accelerate the development and deployment of AI-powered solutions for the Healthcare and Life Sciences (HLS) industry. The collaboration will help HLS organizations advance computational drug discovery and improve research outcomes using Generative AI and advanced analytics.
About this update from Persistent Systems Limited
[{"type":"text","content":"Reimagining early-stage drug discovery leveraging NVIDIA BioNeMo Framework","length":74,"tagName":"p"},{"type":"text","content":"SANTA CLARA, Calif. and PUNE, India, March 17, 2026 /PRNewswire/ -- Persistent Systems (BSE: 533179) (NSE: PERSISTENT), a global Digital Engineering and Enterprise Modernization leader, today announced it is working with NVIDIA to accelerate the development and deployment of AI-powered solutions for the Healthcare and Life Sciences (HLS) industry. The collaboration will help HLS organizations advance computational drug discovery and improve research outcomes using Generative AI and advanced analytics.","length":511,"tagName":"p"},{"type":"image","alt":"Persistent_Systems_Logo","displaySize":"","headline":null,"caption":"Persistent_Systems_Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":400,"url":"https://media.zenfs.com/en/prnewswire.com/b499565e645867cf91b59dd2bfa3eceb"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/i_sDo_GWYtASQAFVwQX1rQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTcwNTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/b499565e645867cf91b59dd2bfa3eceb","width":400,"height":400}}},{"type":"text","content":"HLS organizations are under increasing pressure to drive innovation while operating in highly complex, regulated and data-intensive environments. Combining Persistent's deep domain and engineering expertise with the full-stack NVIDIA AI platform, Life Sciences enterprises can move from AI experimentation to real-world production deployments in mission-critical environments.","length":380,"tagName":"p"},{"type":"text","content":"Persistent will leverage NVIDIA AI Enterprise for specialized Life Sciences R&D use cases, including preclinical research. By enabling high-fidelity molecular simulation and virtual screening at scale, the collaboration applies AI to model and reason real-world biological and chemical behavior before it is realized in real-world wet laboratory environments.","length":368,"tagName":"p"},{"type":"text","content":"As part of this collaboration, Persistent will build and deploy production-grade Agentic AI applications for computational drug discovery using NVIDIA NeMo. Specifically, Persistent has created a Generative Molecules and Virtual Screening (GenMoIVS) solution, powered by the NVIDIA BioNeMo ...